Stoke Therapeutics, Inc. · NASDAQ:STOK
Lynx1 Capital Management LP reported a 8.10% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 18, 2026
Lynx1 Capital Management LP reported a 8.10% stake in Stoke Therapeutics, Inc., 4,763,673 shares, as a passive investor on Mar 31, 2026. Filed May 18, 2026 (Schedule 13G/A).
- Stake
- 8.10%
- Shares
- 4,763,673
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lynx1 Capital Management LP | 8.10% | 4,763,673 |
| Weston Nichols | 8.10% | 4,763,673 |
Source
Related
- Stoke Therapeutics, Inc.
- Lynx1 Capital Management LP
- Stoke Therapeutics, Inc. shareholders
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · May 15, 2026
- Form 4 · Allan Jonathan · Oct 2, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026